A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease

Details for Australian Patent Application No. 2001265844 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Pontecorvo, Michael; Parys, Wim Louis Julien

Agent Shelston IP

Pub. Number AU-B-2001265844

PCT Pub. Number WO01/74339

Priority 60194259 03.04.00 US

Filing date 28 March 2001

Wipo publication date 15 October 2001

Acceptance publication date 14 April 2005

International Classifications

A61K 031/00

Event Publications

14 April 2005 Application Accepted

  Published as AU-B-2001265844

11 August 2005 Standard Patent Sealed

23 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001265847

2001265842